Apolipoproteins modulate the inflammatory response to lipopolysaccharide

Area of Science:

• Biochemistry
• Immunology
• Pathophysiology

Background:

• Sepsis significantly impacts lipoprotein metabolism, affecting triglyceride and cholesterol levels.
• Lipoprotein alterations in sepsis include increased very-low-density lipoprotein (VLDL) and decreased low-density lipoprotein (LDL) and high-density lipoprotein (HDL).
• Sepsis influences various apolipoproteins, enzymes, and receptors involved in HDL metabolism.

Purpose of the Study:

• To elucidate the intricate relationship between lipoprotein metabolism and sepsis.
• To investigate the protective roles of lipoproteins and specific apolipoproteins in sepsis.
• To understand how lipopolysaccharide (LPS) affects lipoprotein components and function.

Main Methods:

• Analysis of plasma triglyceride, cholesterol, VLDL, LDL, and HDL levels in sepsis.
• Characterization of apolipoprotein composition, particularly apoAI and apoE, in HDL particles during sepsis.
• In vitro and rodent studies examining the interaction between lipoproteins and LPS.

Main Results:

• Sepsis leads to elevated plasma triglycerides in VLDL due to altered hepatic production and clearance.
• Sepsis reduces plasma cholesterol in LDL and HDL, with specific changes in HDL-associated apolipoproteins (apoAI, apoCI, apoE).
• Lipoprotein classes bind LPS and attenuate the host response; triglyceride-rich lipoproteins and apolipoproteins (apoE, apoAI) demonstrate protective effects in sepsis models.

Conclusions:

• Lipoprotein metabolism is profoundly altered during sepsis, with significant changes in lipid and apolipoprotein profiles.
• Apolipoproteins, rather than lipid components, are likely key mediators of the protective effects of lipoproteins against sepsis.
• Further research into the specific roles of apolipoproteins in sepsis is crucial for understanding this complex interaction.